Markets:

Overview

News

Currencies

International

Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

0.9747 +0.0976 (+11.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate ↗

April 05, 2023

Via Benzinga

Why Is Nuvve (NVVE) Stock Down 14% Today? ↗

April 05, 2023

Nuvve (NVVE) stock is down on Wednesday after the vehicle-to-grid technology company's shares underwent a rally yesterday.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 05, 2023

Via Benzinga

Why Is Secoo (SECO) Stock Down 16% Today? ↗

April 05, 2023

Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday.

Via InvestorPlace

Why Is Immunic (IMUX) Stock Up 23% Today? ↗

April 05, 2023

Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 05, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!

Via InvestorPlace

Preview: Immunic's Earnings ↗

February 22, 2023

Via Benzinga

Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate ↗

November 17, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 15, 2022

Via Benzinga

BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

November 28, 2022

The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 17, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 17, 2022

We're beginning the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

Analyst Downgrades Immunic After Lack of Details Drive Uncertainty ↗

October 21, 2022

Via Benzinga

Immunic's Early Cut Data From Psoriasis Candidate Failed To Show Desired Activity Signal Over Placebo ↗

October 21, 2022

Via Benzinga

Recap: Immunic Q3 Earnings ↗

November 03, 2022

Immunic (NASDAQ:IMUX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Immunic missed estimated earnings...

Via Benzinga

Immunic's Earnings Outlook ↗

November 02, 2022

Immunic (NASDAQ:IMUX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Immunic will report...

Via Benzinga

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Dow Jumps 650 Points; Gold Rises Over 1% ↗

October 21, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 650 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 21, 2022

Gainers

Via Benzinga

Nasdaq Surges 150 Points; Snap Shares Plunge ↗

October 21, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 500 points on Friday.

Via Benzinga

TWTR Stock Alert: Ken Griffin Reportedly Backing Musk’s Twitter Deal ↗

October 21, 2022

Twitter (TWTR) stock is a hot topic among traders today as they react to reports of new backing for Elon Musk's acquisition of the company.

Via InvestorPlace

Veris Residential (VRE) Stock Soars 18% on Buyout Offer ↗

October 21, 2022

Veris Residential (VRE) stock is rising higher on Friday after the company received a buyout offer from Kushner Companies.

Via InvestorPlace

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Why Is Immunic (IMUX) Stock Down 76% Today? ↗

October 21, 2022

Immunic (IMUX) stock is plummeting on Friday after the company reported a high placebo rate in a Phase 1b clinical trial.

Via InvestorPlace

US Stocks Mostly Higher; Dow Jumps 200 Points ↗

October 21, 2022

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 200 points on Friday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 ↗

October 21, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 21, 2022

Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 21, 2022

We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

Why Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket ↗

October 21, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 40.9% to $0.2160 in pre-market trading. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 20, 2022

Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Immunic, Inc. - Common Stock (NQ:IMUX)

Headline News about Immunic, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today